Overview
Chaosheng He practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Adenoid Cystic Carcinoma, Hyperparathyroidism, Pure Red Cell Aplasia, and Minimal Change Disease.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chaosheng He
Is Chaosheng He a top-rated expert for Adenoid Cystic Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Chaosheng He is classified as an Experienced expert for Adenoid Cystic Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chaosheng He participate in research or clinical trials?
Yes. Chaosheng He has published 17 articles and abstracts on conditions like Adenoid Cystic Carcinoma. You can view a list of Chaosheng He's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adenoid Cystic Carcinoma
- HyperparathyroidismHe isExperienced. Learn about Hyperparathyroidism.
- Minimal Change DiseaseHe isExperienced. Learn about Minimal Change Disease.
- Pure Red Cell AplasiaHe isExperienced. Learn about Pure Red Cell Aplasia.